Clovis Oncology, Inc. Additional Paid in Capital
Clovis Oncology, Inc. had Additional Paid in Capital of $778.70 million as of 2014-09-30, per its 10-Q filed 2014-11-07.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent › Additional Paid in Capital
us-gaap:AdditionalPaidInCapital · last filed 2014-11-07
- 2014-09-30: Additional Paid in Capital $778.70M.
- 2014-06-30: Additional Paid in Capital $773.21M.
- 2014-03-31: Additional Paid in Capital $767.23M.
- 2013-12-31: Additional Paid in Capital $762.17M.
| Period end | Additional Paid in Capital |
|---|---|
| 2014-09-30 | $778.70M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $773.21M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $767.23M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $762.17M 10-Q · filed 2014-11-07 |
| 2013-09-30 | $585.24M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $582.41M 10-Q · filed 2013-08-07 |
| 2013-03-31 | $319.82M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $317.90M 10-K · filed 2014-02-28 |
| 2012-09-30 | $316.22M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $314.65M 10-Q · filed 2012-08-10 |
| 2012-03-31 | $243.41M 10-Q · filed 2012-05-11 |
| 2011-12-31 | $242.22M 10-K · filed 2013-03-14 |